Trial Profile
Prospective study investigating effects of addition of Everolimus to existing immunosupressive therapy in treatment of Kidney transplant patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Dec 2015
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Corticosteroids; Mycophenolate mofetil; Tacrolimus
- Indications Renal transplant rejection
- Focus Pharmacokinetics; Therapeutic Use
- 24 Dec 2015 New trial record